Dose-reduced chemo effective in elderly pancreatic cancer patients
from Clinical Oncology News
In a single-center study of elderly patients with advanced pancreatic cancer, reductions in the dose of gemcitabine plus nab-paclitaxel resulted in better tolerability than standard dosing, without compromising survival.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063